Company Filing History:
Years Active: 2001-2007
Title: Celebrating the Innovations of Inventor Rina Das from Rockville, MD
Introduction: Rina Das, an accomplished inventor based in Rockville, MD, has made significant contributions to the field of biomedical innovation. With a total of two patents, her work focuses on critical methods for diagnosing cancer and exposure to toxic agents, showcasing her commitment to health and safety.
Latest Patents: Rina Das holds two notable patents that reflect her expertise and innovative spirit. The first patent involves a "Method of Diagnosing Stage or Aggressiveness of Breast and Prostate Cancer Based on Levels of Fatty Acid Binding Proteins." This method measures the deviation of fatty acid binding protein levels in mammalian tissue or body fluids from normal levels, thereby assisting in identifying the stage or aggressiveness of cancerous conditions. The second patent, titled "Method of Diagnosing Exposure to Toxic Agents by Measuring Distinct Patterns in the Levels of Expression of Specific Genes," describes an innovative approach to detect toxic exposure. It involves comparing the protein and gene expression levels in samples from individuals exposed to toxic agents versus unexposed samples, ultimately determining if there was exposure to specific toxins.
Career Highlights: Rina Das's career includes her role as an inventor within the US Government as represented by the Secretary of the Army. Her work is pivotal in developing diagnostic methods that have far-reaching implications in medical and environmental health.
Collaborations: Throughout her career, Rina has collaborated with esteemed colleagues, including Marti Jett and Chanaka Mendis. These partnerships have fostered a dynamic environment for innovation and research, enhancing the impact of her contributions to science and technology.
Conclusion: Rina Das exemplifies the spirit of innovation through her groundbreaking patents that address pressing health challenges. Her work not only advances the field of cancer diagnosis but also enhances our understanding of toxic exposures. As she continues to push the boundaries of biomedical research, her contributions will undoubtedly influence future advancements in healthcare and safety.